IV Therapy Rules by State: Who Can Order and Push
Who may order and administer elective IV therapy in 14 states, including Texas HB 3749, standing orders, USP 797 immediate use, and records.
Prescribing, dispensing, marketing, and state compliance for wellness, longevity, GLP-1, and weight management practices.
Who may order and administer elective IV therapy in 14 states, including Texas HB 3749, standing orders, USP 797 immediate use, and records.
Video visit, questionnaire-only, and in-person rules for telehealth GLP-1 prescribing, plus nonresident pharmacy registration, in a 14-state table.
The ordered compliance checklist for opening an NP weight loss clinic: practice authority, DEA and PDMP, GLP-1 compounding, consent, marketing, and records.
NP practice authority by state, corporate practice of medicine, MSO structure, and collaborative agreement terms for opening a weight loss clinic in 2026.
Can you still prescribe compounded semaglutide or tirzepatide? The 503A copy test, the four-per-month policy, chart documentation, consent, and vial records.
DEA telemedicine flexibilities end December 31, 2026. What testosterone and phentermine prescribers need to know about the special registration.
A weight loss clinic EHR requirements checklist built from the FDA, DEA, HIPAA, IRS and state rules, with a question to put to every vendor.
State auto-renewal rules for clinic memberships in 2026, including New York City's October click-to-cancel rule and the FTC rollback.
What HIPAA actually requires of an intake form vendor: business associate status, Security Rule safeguards, and the 2025 proposed update.